Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study
Pharmacyclics LLC.
David Bernard Miklos; Mohammad Abu Zaid; Julian P Cooney; Jörn C Albring; Mary Flowers; Alan P Skarbnik; Ibrahim Yakoub-Agha; Bor-Sheng Ko; Benedetto Bruno; Edmund K Waller; Jean Yared; Sang Kyun Sohn; Claude-Eric Bulabois; Takanori Teshima; David Jacobsohn; Hildegard Greinix; Ahmad Mokatrin; Yihua Lee; Justin T Wahlstrom; Lori Styles; Gerard Socie